AgeRate, Longan Vision & Epineuron Technologies Accepted into CDL

October 3, 2019

We are proud to announce that our alumni AgeRate, Longan Vision, and Epineuron have been accepted into the 2019/2020 cohort of the Creative Destruction Lab (CDL), where they will attend a nine-month program that will focus on maximizing equity-value creation. The Creative Destruction Lab is a seed-stage program for scalable science-based companies.  This is an incredible opportunity for both AgeRate and Longan Vision to continue to grow their successful businesses.

AgeRate provides an epigenetic test that can accurately and affordably reveal your biological age.
Longan Vision is developing an AR visor glass-Fusion Vision System (FVS) for firefighters to locate victims in harsh environments.
Epineuron Technology is a developmental-stage medical device company creating the first temporary wearable therapeutic that delivers bioelectronic medicine to injured peripheral nerves.